These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26256010)

  • 1. Role of serotonin 5-HT2C and histamine H1 receptors in antipsychotic-induced diabetes: A pharmacoepidemiological-pharmacodynamic study in VigiBase.
    Montastruc F; Palmaro A; Bagheri H; Schmitt L; Montastruc JL; Lapeyre-Mestre M
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1556-65. PubMed ID: 26256010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor occupancy-based analysis of the contributions of various receptors to antipsychotics-induced weight gain and diabetes mellitus.
    Matsui-Sakata A; Ohtani H; Sawada Y
    Drug Metab Pharmacokinet; 2005 Oct; 20(5):368-78. PubMed ID: 16272755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between receptor binding affinity and metabolic side effect profile of antipsychotics and major cardio- and cerebrovascular events: A case/non-case study using VigiBase.
    Aguiar JP; Alves da Costa F; Egberts T; Leufkens H; Souverein P
    Eur Neuropsychopharmacol; 2020 Jun; 35():30-38. PubMed ID: 32409260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes.
    Silvestre JS; Prous J
    Methods Find Exp Clin Pharmacol; 2005 Jun; 27(5):289-304. PubMed ID: 16082416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H1-histamine receptor affinity predicts weight gain with antidepressants.
    Salvi V; Mencacci C; Barone-Adesi F
    Eur Neuropsychopharmacol; 2016 Oct; 26(10):1673-7. PubMed ID: 27593622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An original pharmacoepidemiological-pharmacodynamic method: application to antipsychotic-induced movement disorders.
    Nguyen TT; Pariente A; Montastruc JL; Lapeyre-Mestre M; Rousseau V; Rascol O; Bégaud B; Montastruc F
    Br J Clin Pharmacol; 2017 Mar; 83(3):612-622. PubMed ID: 27687785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Serotonin Transporter in Antidepressant-Induced Diabetes Mellitus: A Pharmacoepidemiological-Pharmacodynamic Study in VigiBase
    Nguyen TTH; Roussin A; Rousseau V; Montastruc JL; Montastruc F
    Drug Saf; 2018 Nov; 41(11):1087-1096. PubMed ID: 29956218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro pharmacological evaluation of a new series of 5-HT1A 5-HT2A and 5-HT2C receptor ligands containing a norbornene nucleus.
    Fiorino F; Severino B; De Angelis F; Perissutti E; Magli E; Frecentese F; Esposito A; Massarelli P; Nencini C; Viti B; Santagada V; Caliendo G
    Pharmazie; 2009 Sep; 64(9):555-64. PubMed ID: 19827295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study focuses in on potential cause of antipsychotic-induced diabetes.
    O'Neill MF
    Drug News Perspect; 2005 Oct; 18(8):481-2. PubMed ID: 16391716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor mechanisms in the treatment of schizophrenia.
    Reynolds GP
    J Psychopharmacol; 2004 Sep; 18(3):340-5. PubMed ID: 15358977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A positron emission tomography occupancy study of brexpiprazole at dopamine D
    Girgis RR; Forbes A; Abi-Dargham A; Slifstein M
    Neuropsychopharmacology; 2020 Apr; 45(5):786-792. PubMed ID: 31847007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QF2004B, a potential antipsychotic butyrophenone derivative with similar pharmacological properties to clozapine.
    Brea J; Castro M; Loza MI; Masaguer CF; Raviña E; Dezi C; Pastor M; Sanz F; Cabrero-Castel A; Galán-Rodríguez B; Fernández-Espejo E; Maldonado R; Robledo P
    Neuropharmacology; 2006 Aug; 51(2):251-62. PubMed ID: 16697427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of genetic variants of the histamine H1 and muscarinic M3 receptors with BMI and HbA1c values in patients on antipsychotic medication.
    Vehof J; Risselada AJ; Al Hadithy AF; Burger H; Snieder H; Wilffert B; Arends J; Wunderink L; Knegtering H; Wiersma D; Cohen D; Mulder H; Bruggeman R
    Psychopharmacology (Berl); 2011 Jul; 216(2):257-65. PubMed ID: 21336576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhabdomyolysis reported for children and adolescents treated with antipsychotic medicines: a case series analysis.
    Star K; Iessa N; Almandil NB; Wilton L; Curran S; Edwards IR; Wong IC
    J Child Adolesc Psychopharmacol; 2012 Dec; 22(6):440-51. PubMed ID: 23234587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds.
    Richelson E; Souder T
    Life Sci; 2000 Nov; 68(1):29-39. PubMed ID: 11132243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signalling profile differences: paliperidone versus risperidone.
    Clarke WP; Chavera TA; Silva M; Sullivan LC; Berg KA
    Br J Pharmacol; 2013 Oct; 170(3):532-45. PubMed ID: 23826915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological profile of 2-bromoterguride at human dopamine D2, porcine serotonin 5-hydroxytryptamine 2A, and α2C-adrenergic receptors, and its antipsychotic-like effects in rats.
    Jantschak F; Brosda J; Franke RT; Fink H; Möller D; Hübner H; Gmeiner P; Pertz HH
    J Pharmacol Exp Ther; 2013 Oct; 347(1):57-68. PubMed ID: 23863695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.
    Kroeze WK; Hufeisen SJ; Popadak BA; Renock SM; Steinberg S; Ernsberger P; Jayathilake K; Meltzer HY; Roth BL
    Neuropsychopharmacology; 2003 Mar; 28(3):519-26. PubMed ID: 12629531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and binding affinity of potential atypical antipsychotics with the tetrahydroquinazolinone motif.
    Carro L; Raviña E; Domínguez E; Brea J; Loza MI; Masaguer CF
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6059-62. PubMed ID: 19796944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice.
    Stahl SM; Shayegan DK
    J Clin Psychiatry; 2003; 64 Suppl 19():6-12. PubMed ID: 14728084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.